Antidepressant Decision Aid for Major Depressive Disorder Patients
Antidepressant Decision Aid for Major Depressive Disorder Patients
The purpose of this study is to determine whether Antidepressant Decision Aid for Major
 Depressive Disorder is feasible and effective in involving patients in the decision-making
 process when initiating pharmacotherapy.
To examine the ability of the patient decision aid to enhance shared decision making and
 preparedness to make decisions pertaining to antidepressant therapy. The research team has
 systematically developed an Antidepressant Decision Aid for Major depressive disorder
 patients (ADAM) according to the International Patient Decision Aids Standards (IPDAS) and
 the Ottawa Decision Support Framework. This is a posttest-only study with nonequivalent
 groups to evaluate the effect of the antidepressant decision aid on patient and physician
 perception of shared decision making as well as patient preparedness for making
 pharmacotherapeutic decisions compared usual care.
Inclusion Criteria:

 -  Diagnosed with Major Depressive Disorder (MDD)

 -  No psychotic symptoms

 -  Based on psychiatrist's clinical judgement currently in need for antidepressant
 treatment.

 -  Functional English literacy and language skills (to use the decision aid and fill out
 the questionnaires)

 -  Provides consent

 Exclusion Criteria:

 -  Psychosis

 -  Communication barriers (visual impairment, language barrier)